enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. A new Alzheimer’s drug will cost $26,500 a year. Who will be ...

   www.aol.com/news/alzheimer-drug-cost-26-500...

   A newly approved drug intended to slow the progression of Alzheimer’s disease offers patients hope, but it will come with a steep price tag: $26,500 a year. A new Alzheimer’s drug will cost ...

3. A Revolutionary New Alzheimer’s Drug Was Just Approved by the ...

   www.aol.com/revolutionary-alzheimer-drug-just...

   Lecanemab (a.k.a. leqembi) has received full approval from the U.S. Food and Drug Administration. This is the first FDA-approved treatment to help slow the progression of Alzheimer’s disease.

4. What you need to know about newly approved Alzheimer's drug - AOL

   www.aol.com/finance/know-newly-approved...

   A dozen things to know about the new Alzheimer's drug On July 5, the FDA fully approved Lecanemab (brand name: Leqembi) as a treatment for patients in the early stages of Alzheimer's disease.

5. New Alzheimer's Drug Costly, Could Be Risky - AOL

   www.aol.com/alzheimers-drug-costly-could-risky...

   Alzheimer's patients could pay roughly $75,000 each year for treatment and medical costs related to the IV drug aducanumab (also known as aduhelm), according to new peer-reviewed analysis from the ...

6. Donanemab – what we know about the latest Alzheimer’s drug

   www.aol.com/donanemab-know-latest-alzheimer-drug...

   NHS England has published a briefing paper suggesting the cost of bringing new Alzheimer’s disease modifying treatments to the health service could be £500 million to £1 billion per year.

7. FDA grants full approval to new Alzheimer's drug meant to ...

   www.aol.com/news/fda-grants-full-approval...

   The Food and Drug Administration has approved lecanemab, a drug developed by Eisai and Biogen with the goal of slowing the progression of Alzheimer’s disease. FDA grants full approval to new ...